472 related articles for article (PubMed ID: 15064017)
1. Preclinical studies on how to deal with patient intolerance to nicotinamide and carbogen.
Horsman MR; Overgaard J
Radiother Oncol; 2004 Mar; 70(3):301-9. PubMed ID: 15064017
[TBL] [Abstract][Full Text] [Related]
2. Enhanced local tumour control after single or fractionated radiation treatment using the hypoxic cell radiosensitizer doranidazole.
Murata R; Tsujitani M; Horsman MR
Radiother Oncol; 2008 Jun; 87(3):331-8. PubMed ID: 18375007
[TBL] [Abstract][Full Text] [Related]
3. Comparison of the effectiveness of tirapazamine and carbogen with nicotinamide in enhancing the response of a human tumor xenograft to fractionated irradiation.
el-Said A; Menke D; Dorie MJ; Brown JM
Radiat Oncol Investig; 1999; 7(3):163-9. PubMed ID: 10406058
[TBL] [Abstract][Full Text] [Related]
4. Reducing acute and chronic hypoxia in tumours by combining nicotinamide with carbogen breathing.
Horsman MR; Nordsmark M; Khalil AA; Hill SA; Chaplin DJ; Siemann DW; Overgaard J
Acta Oncol; 1994; 33(4):371-6. PubMed ID: 8018368
[TBL] [Abstract][Full Text] [Related]
5. Tumour-specific enhancement of thermoradiotherapy at mild temperatures by the vascular targeting agent 5,6-dimethylxanthenone-4-acetic acid.
Murata R; Horsman MR
Int J Hyperthermia; 2004 Jun; 20(4):393-404. PubMed ID: 15204520
[TBL] [Abstract][Full Text] [Related]
6. Hypoxic radiosensitizers in radical radiotherapy for patients with bladder carcinoma: hyperbaric oxygen, misonidazole, and accelerated radiotherapy, carbogen, and nicotinamide.
Hoskin PJ; Saunders MI; Dische S
Cancer; 1999 Oct; 86(7):1322-8. PubMed ID: 10506720
[TBL] [Abstract][Full Text] [Related]
7. Hyperbaric oxygen improves tumor radiation response significantly more than carbogen/nicotinamide.
Brizel DM; Hage WD; Dodge RK; Munley MT; Piantadosi CA; Dewhirst MW
Radiat Res; 1997 Jun; 147(6):715-20. PubMed ID: 9189170
[TBL] [Abstract][Full Text] [Related]
8. Accelerated radiotherapy, carbogen, and nicotinamide (ARCON) in the treatment of advanced bladder cancer: mature results of a Phase II nonrandomized study.
Hoskin P; Rojas A; Saunders M
Int J Radiat Oncol Biol Phys; 2009 Apr; 73(5):1425-31. PubMed ID: 19036531
[TBL] [Abstract][Full Text] [Related]
9. Radiosensitizing effect of nicotinamide and carbogen combined in fractionated pions or x-rays in SCCVII tumors.
Ohizumi Y; Lam GK; Pickles T; Fryer C; Chaplin DJ
Radiat Med; 1995; 13(6):291-5. PubMed ID: 8850370
[TBL] [Abstract][Full Text] [Related]
10. Radiosensitisation in normal tissues with oxygen, carbogen or nicotinamide: therapeutic gain comparisons for fractionated x-ray schedules.
Rojas A; Vojnovic B; Johns H; Joiner MC; Martindale C; Fowler JF; Denekamp J
Radiother Oncol; 1996 Apr; 39(1):53-64. PubMed ID: 8735494
[TBL] [Abstract][Full Text] [Related]
11. Carbogen and nicotinamide as radiosensitizers in a murine mammary carcinoma using conventional and accelerated radiotherapy.
Rojas A; Hirst VK; Calvert AS; Johns H
Int J Radiat Oncol Biol Phys; 1996 Jan; 34(2):357-65. PubMed ID: 8567336
[TBL] [Abstract][Full Text] [Related]
12. Nicotinamide as a repair inhibitor in vivo: studies using single and fractionated X-ray doses in mouse skin and kidneys.
Rojas A; Denekamp J; Johns H; Kjellen E; Tsang R; Nilsson P; Stratford MR; Dennis MF; Joiner MC
Radiat Res; 1996 Apr; 145(4):419-31. PubMed ID: 8600502
[TBL] [Abstract][Full Text] [Related]
13. Combination of nicotinamide and hyperthermia to eliminate radioresistant chronically and acutely hypoxic tumor cells.
Horsman MR; Chaplin DJ; Overgaard J
Cancer Res; 1990 Dec; 50(23):7430-6. PubMed ID: 2147577
[TBL] [Abstract][Full Text] [Related]
14. Tumor R2* is a prognostic indicator of acute radiotherapeutic response in rodent tumors.
Rodrigues LM; Howe FA; Griffiths JR; Robinson SP
J Magn Reson Imaging; 2004 Apr; 19(4):482-8. PubMed ID: 15065173
[TBL] [Abstract][Full Text] [Related]
15. Preferential action of arsenic trioxide in solid-tumor microenvironment enhances radiation therapy.
Griffin RJ; Williams BW; Park HJ; Song CW
Int J Radiat Oncol Biol Phys; 2005 Apr; 61(5):1516-22. PubMed ID: 15817358
[TBL] [Abstract][Full Text] [Related]
16. The combination of nicotinamide and carbogen breathing to improve tumour oxygenation prior to radiation treatment.
Horsman MR; Siemann DW; Nordsmark M; Khalil AA; Overgaard J; Chaplin DJ
Adv Exp Med Biol; 1994; 361():635-42. PubMed ID: 7597993
[No Abstract] [Full Text] [Related]
17. Effects of Fluosol DA 20% and carbogen on the radioresponse of SCK tumors and skin of A/J mice.
Lee I; Levitt SH; Song CW
Radiat Res; 1987 Oct; 112(1):173-82. PubMed ID: 3116597
[TBL] [Abstract][Full Text] [Related]
18. Fractionated irradiation combined with carbogen breathing and nicotinamide of two human glioblastomas grafted in nude mice.
Sun LQ; Coucke PA; Mirimanoff RO; Buchegger F
Radiat Res; 2001 Jan; 155(1 Pt 1):26-31. PubMed ID: 11121212
[TBL] [Abstract][Full Text] [Related]
19. Restoration of tumor oxygenation after cytotoxic therapy by a perflubron emulsion/carbogen breathing.
Teicher BA; Holden SA; Ara G; Dupuis NP; Goff D
Cancer J Sci Am; 1995; 1(1):43-8. PubMed ID: 9166453
[TBL] [Abstract][Full Text] [Related]
20. Radiation administered as a large single dose or in a fractionated schedule: Role of the tumour vasculature as a target for influencing response.
Horsman MR; Nielsen T; Østergaard L; Overgaard J
Acta Oncol; 2006; 45(7):876-80. PubMed ID: 16982553
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]